Blueberries Medical Corp. appointed Jose Maria Forero to its board, effective May 19, 2023. Mr. Forero brings a wealth of experience and a proven track record of success in sales and commercial development.

As the former President of Latin American Operations and a C-level executive with over 17 years of regional and global sales experience, including at Clever Leaves, Mr. Forero possesses extensive knowledge of the global cannabis industry. Mr. Forero holds an Executive MBA degree from INALDE Business School and is an Industrial Engineer. With his operational and sales expertise, he will play a vital role in guiding its company's international expansion and driving growth in new markets.

The Board Member Sebastian Hochbaum has resigned to his position on May 30, 2023 due to personal and professional new challenges. With the appointment of Mr. Forero, its board of directors now consists of five members, including Chairman and Interim CEO Facundo Garretón, Patricio Villalba, Catherine Lathwell, and Joaquin Barrera. The Audit Committee of the Board is composed of Catherine Lathwell, Patricio Villalba, and Facundo Garretón. In line with these structural changes, the company announced the appointment of Gustavo Gutierrez as the new Country Manager of Blueberries SAS in Bogota, Colombia.

Previously serving as the company's Chief Operating Officer, Gustavo is a highly motivated Pharmaceutical Chemist with a master's degree in Biotechnology. His experience in pharmaceutical quality control and his leadership within the company make him an ideal choice to lead its operations in Colombia.